FDA Inspection 1147352 — Pablo E. Pergola, M.D., Ph.D.
The FDA completed an inspection of Pablo E. Pergola, M.D., Ph.D. on July 22, 2021 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 22, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional Details
Clinical Investigator (CI)